NitroSecurity
Venture Round in 2010
NitroSecurity is a supplier of Unified Information Security solutions that provide Edge-to-Core network security for enterprises across many vertical markets, including healthcare, education, financial services, government, retail, hospitality, and managed services. Leveraging patented data management technology, NitroSecurity delivers an integrated, cost effective network security product suite for security information & event management, log management, database activity monitoring, network analysis and intrusion prevention.
NitroSecurity
Series D in 2008
NitroSecurity is a supplier of Unified Information Security solutions that provide Edge-to-Core network security for enterprises across many vertical markets, including healthcare, education, financial services, government, retail, hospitality, and managed services. Leveraging patented data management technology, NitroSecurity delivers an integrated, cost effective network security product suite for security information & event management, log management, database activity monitoring, network analysis and intrusion prevention.
Bluenog Corporation is an enterprise software and solutions provider based in Somerset, New Jersey, founded in 2006. The company specializes in developing software applications and integrations primarily utilizing Oracle technologies. Bluenog offers a range of services including content management, collaboration, business intelligence, and portal solutions, focusing on enhancing service-oriented architecture and information management. Its software facilitates seamless connections between third-party applications and Oracle systems, improving operational efficiency across various industries such as healthcare, finance, retail, and telecommunications. Additionally, Bluenog provides implementation and support services to ensure effective use of its solutions.
EKR Therapeutics
Series B in 2006
EKR Therapeutics, Inc. is a specialty pharmaceutical company based in Bedminster, New Jersey, established in 2005. The company is dedicated to acquiring, developing, and commercializing prescription products that primarily focus on oncology supportive care. EKR Therapeutics addresses various medical conditions, including oral mucositis, stomatitis, xerostomia, nutritional issues, cachexia, skin reactions, bone marrow depression, and pain management, among others. Their products are designed to support the needs of patients in acute-care hospital settings, particularly cancer patients, by providing effective treatments for complications related to cancer and other conditions.
Sopherion Therapeutics
Series B in 2004
Sopherion Therapeutics, LLC is a privately held biopharmaceutical company based in Princeton, New Jersey, with additional offices in Cheshire, Connecticut, and Estero, Florida, as well as a subsidiary in Toronto, Canada. The company specializes in the development and commercialization of oncology therapies, notably Myocet™, a liposome-encapsulated doxorubicin-citrate complex designed to reduce cardiotoxicity. Sopherion holds an exclusive licensing agreement with Cephalon, Inc. for Myocet™ in the United States and Canada. The firm is currently conducting a Phase III global trial to evaluate Myocet™ in combination with Herceptin® and Taxol for treating invasive, metastatic breast cancer. This trial, which aims to recruit 363 patients across twelve countries, builds on promising Phase II results that demonstrated a 96% response rate and a median progression-free survival of two and a half years. Myocet™ is already registered for use in Canada and Europe in combination with cyclophosphamide for similar indications. Sopherion is also exploring additional oncology agents through its Minicell Peptide Display screening technologies.
Othera Pharmaceuticals
Series B in 2004
Othera Pharmaceuticals, Inc. is a specialty pharmaceutical company based in Exton, Pennsylvania, established in 2002. The company is dedicated to developing proprietary treatments for ophthalmic diseases. Its product lineup includes OT-551, which targets geographic atrophy and dry age-related macular degeneration, OT-730, a small molecule oculoselective beta-blocker designed to reduce elevated intraocular pressure associated with glaucoma, and OT-440, a neuroprotectant aimed at providing therapeutic benefits for glaucoma patients. Through its focused approach, Othera Pharmaceuticals aims to address significant unmet needs in the field of ophthalmology.
CorrectNet
Series B in 2004
CorrectNet is a leading provider of managed service-based information delivery and client reporting solutions tailored for the investment management sector. Established in 1997, the company specializes in the aggregation, enrichment, quality assurance, and formatting of complex investment data. It serves some of the largest investment management firms globally, offering tools such as the InfiPOINT platform for client reporting and Advisor WebTools for wealth advisors. CorrectNet is recognized for its capability to meet the stringent transparency and reporting requirements of hedge funds, funds of funds, fund administrators, and prime brokers, delivering comprehensive reporting through sophisticated web portals designed for investors, portfolio managers, operations teams, and executives.
Fiberlink
Series C in 2003
Fiberlink Communications Corporation provides mobility as a service (MaaS) that helps enterprises to connect, control, and secure laptops and mobile devices. Its MaaS Platform helps mobile workers to connect to the Internet and the applications and data they need. The company's MaaS platform is used to perform identity management and authentication services; deploy, monitor, and manage security and connectivity applications on laptops and PCs; view information on compliance status, security events, and connectivity costs; and protect mobile devices and the data from loss, theft, data leakage, hackers, and viruses. Its MaaS360 mobility platform manages security and connectivity services on mobile and remote devices, as well as helps administrators to deploy, monitor, update, and remediate various endpoint security and connectivity applications.
CorrectNet
Series A in 2001
CorrectNet is a leading provider of managed service-based information delivery and client reporting solutions tailored for the investment management sector. Established in 1997, the company specializes in the aggregation, enrichment, quality assurance, and formatting of complex investment data. It serves some of the largest investment management firms globally, offering tools such as the InfiPOINT platform for client reporting and Advisor WebTools for wealth advisors. CorrectNet is recognized for its capability to meet the stringent transparency and reporting requirements of hedge funds, funds of funds, fund administrators, and prime brokers, delivering comprehensive reporting through sophisticated web portals designed for investors, portfolio managers, operations teams, and executives.
Ripple Technologies
Series B in 2001
Ripple Technologies specializes in data access and database monitoring solutions, offering products designed to enhance security and compliance in enterprise environments. Among its key offerings are RippleTech Informant, a tool for monitoring and analyzing adverse data access trends, and RippleTech LogCaster, which facilitates log and event management to track application access and generate reports for auditing purposes. The company serves a diverse range of sectors including finance, telecommunications, healthcare, technology, manufacturing, pharmaceuticals, government, and educational institutions. Founded in 1998 and headquartered in Conshohocken, Pennsylvania, Ripple Technologies has formed strategic partnerships with major firms such as IBM, Microsoft, MySQL Enterprise, and Oracle. As of 2008, it operates as a subsidiary of NitroSecurity.
Step 9 Software
Series B in 2000
Step 9 Software offers web-enabled, pre-integrated operational support systems for communication providers.
iSun Networks
Series A in 2000
iSun Networks is a U.S.-based company founded in 2000 by Byron Guernsey, specializing in software infrastructure for educational institutions. The company develops tools that allow colleges and universities to create and manage dynamic virtual communities tailored to specific affinity groups. By focusing on enhancing interaction among these groups, iSun Networks provides customizable solutions that support and maintain these online environments, thereby improving engagement and communication within educational settings.
Omnient Corporation
Series A in 2000
Teaming with you, Omnient provides one-stop solutions for all of your e-business and e-commerce needs. They explore your vision and analyze your options, making sense of internet technology and mapping the best routes. They help you plan for growth... and the unexpected.
Fiberlink
Venture Round in 2000
Fiberlink Communications Corporation provides mobility as a service (MaaS) that helps enterprises to connect, control, and secure laptops and mobile devices. Its MaaS Platform helps mobile workers to connect to the Internet and the applications and data they need. The company's MaaS platform is used to perform identity management and authentication services; deploy, monitor, and manage security and connectivity applications on laptops and PCs; view information on compliance status, security events, and connectivity costs; and protect mobile devices and the data from loss, theft, data leakage, hackers, and viruses. Its MaaS360 mobility platform manages security and connectivity services on mobile and remote devices, as well as helps administrators to deploy, monitor, update, and remediate various endpoint security and connectivity applications.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.